Care
HIMSS22
Hospital at home and remote patient monitoring are creating a revamped care model, according to Ryan Bertram, principal at the Chartis Group, and Michael Capriotti, senior vice president of integration and strategic operations at Virtua Health.
Its fresh funds will support its product development and international expansion efforts.
SPONSORED
Joe Kvedar, MD, chair of the board of directors for the American Telemedicine Association, previews the upcoming ATA 2022 Conference and Expo, May 1-3, in Boston, and covers the chief topics attendees will learn about.
The startup scooped up $14 million in Series A funding in January 2021.
Hinge's new offering comes nearly two months after competitor SWORD Health announced its own pelvic health program.
HIMSS22
Mytonomy’s novel CRM employs high-quality video content to train patients to manage their chronic illnesses, according to CEO and cofounder Anjali Kataria.
It plans to expand its coverage in the domestic market.
Also: Impiricus raises a $3 million seed, and health tech VC Flare Capital Partners closes its $350 million third fund.
The offering includes treatment and screening for prediabetes and Type 2 diabetes.
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.